SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as the community discusses the stock's volatility and potential for a short squeeze. Recent news of a contract win is fueling optimism, though a proposed increase in authorized shares has sparked concerns about dilution. Bullish investors are focused on the company's long-term prospects in the drone and counter-UAS technology sectors.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending following positive data from Roche on a similar breast cancer drug, sparking significant intraday volatility and a surge in price. The community is actively debating whether this jump is justified, discussing potential short squeezes, imminent offerings, and the overall valuation of OLMA in light of the news. Some traders are wary of a potential pullback, while others see further upside based on pipeline potential and analyst upgrades.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending due to its GPU-accelerated quantum algorithm simulation and compatibility with NVIDIA's CUDA-Q, sparking discussions about accelerated quantum computing. Investors are speculating on potential partnerships, future growth, and the company's positioning within the quantum computing sector. Community members are also discussing the potential for a short squeeze.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as retail investors discuss the stock holding its 200-day moving average and anticipate a breakout, with some pointing to a potential 'W' pattern forming. Community members are actively trading the swings and expressing excitement around potential catalysts, including a possible World Cup contract and Nvidia's earnings. Bullish sentiment seems to be increasing as traders hope for a power hour surge and speculate on news of new contracts soon.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending as community members speculate about a potential acquisition by Nestle, fueled by rumors and recent activity, including workforce reductions.  The discussion revolves around a possible buyout price and what a deal would mean for shareholders.  Some traders are pointing to technical indicators and options activity, while others express frustration with the company's long-term performance and management.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as anticipation builds for presentations at the upcoming AASLD Liver Meeting, with the community focused on new biomarker data and potential partnerships. Discussion is centered on Belapectin's potential synergy with GLP-1 drugs and speculation about a possible short squeeze, given the high short interest. Investors are closely watching for any indications of a potential buyout before the year's end.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending amid anticipation for its earnings report, with the community debating whether AI demand justifies current valuations. Discussions include potential sales of advanced AI chips to Saudi Arabia and comparisons to past market bubbles, while some traders are closely watching for a potential breakout.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target (TGT) is trending as investors anticipate upcoming earnings and assess its potential as a value play, considering its lower valuation compared to industry peers. Community members are weighing the possibility of a post-earnings move to $100+, while some caution against potential economic headwinds impacting retail and consumer spending during the holiday season.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

ARWR is trending due to the FDA approval of REDEMPLO for familial chylomicronemia syndrome, marking its first drug approval. The community is excited about the company transitioning to a commercial stage and its robust pipeline, with some drawing comparisons to ALNY's market capitalization. Discussions also revolve around the drug's advantages over competitors and potential partnerships.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot's stock is trending despite mixed Q2 earnings, as investors focus on the company's reaffirmed guidance and underlying strength in smaller home improvement projects. Community discussions revolve around the potential impact of tariffs and the competitive landscape with Lowe's, with some questioning the high valuation relative to growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Consolidated Water (NASDAQ:CWCO) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Consolidated Water from a "hold" rating to a "buy" rating in a research note on Sunday...

Roth Capital Predicts Weaker Earnings for Consolidated Water

Consolidated Water Co. Ltd. (NASDAQ:CWCO - Free Report) - Equities research analysts at Roth Capital reduced their FY2026 earnings per share (EPS) estimates for Consolidated Water in a research note...

Aviva PLC Makes New Investment in Consolidated Water Co. Ltd. $CWCO

Aviva PLC purchased a new stake in Consolidated Water Co. Ltd. (NASDAQ:CWCO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...

Equities Analysts Issue Forecasts for CWCO FY2025 Earnings

Consolidated Water Co. Ltd. (NASDAQ:CWCO - Free Report) - Equities researchers at Roth Capital boosted their FY2025 EPS estimates for shares of Consolidated Water in a note issued to investors on...

Consolidated Water Q3 Earnings and Sales Surpass Estimates 

Consolidated Water posts strong third-quarter results with earnings and revenues beating estimates, driven by robust service performance.

Consolidated Water (NASDAQ:CWCO) Sets New 52-Week High After Earnings Beat

Consolidated Water (NASDAQ:CWCO) Reaches New 12-Month High Following Earnings Beat...

Consolidated Water (NASDAQ:CWCO) Issues Earnings Results

Consolidated Water (NASDAQ:CWCO - Get Free Report) released its quarterly earnings results on Monday. The utilities provider reported $0.34 earnings per share for the quarter, topping analysts...

Consolidated Water (CWCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Consolidated Water (CWCO) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Consolidated Water Co's Earnings: A Preview

Telus (TU) Misses Q3 Earnings and Revenue Estimates

Telus (TU) delivered earnings and revenue surprises of -10.53% and -0.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Consolidated Water Co. Ltd. engages in the development and operation of seawater desalination plants and water distribution systems. It operates through the following segments: Retail, Bulk, Services, and Manufacturing. The Retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Islands. The Bulk segment supplies potable water to government utilities in Grand Cayman and the Bahamas. The Services segment designs, constructs, and sells water infrastructure; and provides management and operating services to third parties. The Manufacturing segment focuses on the manufacture and service of custom and specialized water-related products applicable to commercial, municipal and industrial water production, supply, and treatment. The company was founded in 1973 and is headquartered in George Town, Cayman Islands.

CWCO
Consolidated Water Co. Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CWCO News

CWCOConsolidated Water Co. Ltd.